Skip to content

Viking Therapeutics VKTX Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-70%-55.6pp-47.3%-29.4pp-29.2%-13.7pp-20%-5.2pp-14.4%+3.1pp
Return on assets-64%-50.1pp-44.3%-27.1pp-28.3%-13.3pp-19.3%-5.0pp-14%+2.8pp
Efficiency
Asset turnover
Liquidity
Current ratio5.7×-38.5×9.3×-23.8×28.3×-8.1×25.9×-11.8×44.2×+14.8×
Quick ratio5.7×-38.5×9.3×-23.8×28.3×-8.1×25.9×-11.8×44.2×+14.8×
Cash ratio1.1×-0.8×2.2×+1.2×3.9×+1.9×1.1×-0.7×1.9×-4.0×
Leverage
Interest coverage-16.9×-13.0×-11.7×-8.0×-7.3×-3.5×-5.2×-0.7×-3.9×+1.6×
Per Share
Book value per share$4.34-42.5%$5.67-29.7%$6.35-22.8%$7.09-15.0%$7.56-16.3%
Valuation
Market capitalization$3.76B+38.7%$3.98B-11.3%$2.96B-57.7%$3.03B-44.8%$2.71B-68.0%
Price / book7.5×+4.3×6.2×+1.1×4.1×-3.5×3.8×-2.1×3.2×-5.9×
Earnings yield-12.6%-7.8pp-9%-6.6pp-8%-6.6pp-5.7%-3.9pp-4.7%-3.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Viking Therapeutics's ratios come from?
Every ratio is computed from Viking Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.